Carrier-mediated drug transport is relatively unexplored in comparison with
passive transcellular and paracellular drug transport. Yet, there is a hos
t of transporter proteins that can be targeted for improving epithelial dru
g absorption. Generally, these are transport mechanisms for amino acids, di
peptides, monosaccharides, monocarboxylic acids, organic cations, phosphate
s, nucleosides, and water-soluble vitamins. Among them, the dipeptide trans
porter mechanism has received the most attention. Dipeptide transporters ar
e H+-coupled, energy-dependent transporters that are known to play an essen
tial role in the oral absorption of beta -lactam antibiotics, an,angiotensi
n-converting enzyme (ACE) inhibitors, renin inhibitors, and an anti-tumor d
rug, bestatin. Moreover, several investigators have demonstrated the utilit
y of the dipeptide transporter as a platform for improving the oral bioavai
lability of drugs such as zidovudine and acyclovir through dipeptide prodru
g derivatization. Thus far, at least four proton-coupled peptide transporte
rs have been cloned. The first one cloned was PepT1 from the rabbit small i
ntestine. The focus of this presentation will be structure-function, intrac
ellular trafficking, and regulation of PepT1. Disease, dietary, and possibl
e excipient influences on PepT1 function will also be discussed. (C) 2000 E
lsevier Science B.V. All rights reserved.